English

EntityQ5347187· pop 6· linked from 1,058 articles

efaroxan

Efaroxan is an α2-adrenergic receptor antagonist and antagonist of the imidazoline receptor.

Research

304 papers

Idazoxan and Efaroxan Potentiate the Endurance Performances and the Antioxidant Activity of Ephedrine in Rats.Medicina (Kaunas, Lithuania) · 2021
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy.Movement disorders : official journal of the Movement Disorder Society · 1998
Efaroxan acts peripherally to block the antisecretory and gastroprotective effects of moxonidine in rats.The Journal of pharmacology and experimental therapeutics · 1995
Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.Diabetes · 2001
Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell.British journal of pharmacology · 2002

via PubMed

Wikidata facts

Mass: 216.126

~1 min read

Article

4 sections

Contents

Synthesis
See also
References
External links

Efaroxan is an α2-adrenergic receptor antagonist and antagonist of the imidazoline receptor.

==Synthesis== thumb|center|500px|class=skin-invert-image|Synthesis (Cmp#13): Revised:

Available in 5 languages

via Wikidata sitelinks · CC0

Connections

Similar entities

Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).

efaroxan

Research

Wikidata facts

Article

Available in 5 languages

Connections

What links here1,058 pages

Similar entities

Categories

Similar entities

What links here1,058 pages